Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Regulatory/Medical Affairs), And Segment Forecasts, 2021 - 2028
Healthcare Contract Research Organization Market Growth & Trends
The global healthcare contract research organization market size is expected to reach USD 68.0 billion by 2028. The market is expected to expand at a CAGR of 6.6% from 2021 to 2028. The increasing cost of drug development is expected to drive the market demand over the forecast period. Additionally, rising clinical trials cost and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and the Middle East for cost savings and quick patient recruitment.
In addition, the growing pressure on the industry players to follow stringent timelines has increased the demand for outsourcing research activities to contract research organizations (CROs). Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure, expertise, and minimize their cost and timelines.
However, the COVID-19 pandemic has significantly impacted the CRO market.The worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of other vaccines and drugs.
At the peak of the pandemic, vaccines and treatments for COVID-19 accounted for 30% of all the trials in the U.S. This resulted in other trials being put on hold.
The CRO market is recovering slowly through a hybrid approach.Contract research organizations are playing a significant role in helping sponsors and sites to start clinical trials.
Market players have already built powerful tools to support virtual clinical trials. They are ready to rapidly assist sponsors to shift to this new environment and leverage the available tools.
Healthcare Contract Research Organization Market Report Highlights • By type, the clinical segment dominated the market in 2020 with a revenue share of over 75.0% owing to the fact that it comprises four elaborate phases, including human subjects • Based on service, the clinical monitoring segment held the largest revenue share of over 20.0% in 2020. This can be attributed to the increasing number of clinical trials and the need to monitor those studies that are creating more demand for the services
• North America held the second-largest revenue in 2020 due to the presence of several global players, who invest a major part of their revenue in research activities • Asia Pacific is anticipated to witness the highest growth over the forecast period due to the reduced cost it offers in comparison to the U.S and other developed economies • China, Japan, and India are projected to witness tremendous growth in the years to come owing to the high prevalence of diseases
Our reports have been used by over 10K customers, including:
The global humectants market reached a value of US$ 24.6 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 37.9 Billion by 2027, exhibiting a CAGR of 7.6% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
Microscopic Polyangiitis (MPA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Microscopic Polyangiitis (MPA) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
Report Scope: This report identifies the global preclinical research outsourcing services market, along with all major global preclinical CRO companies.The total preclinical research outsourcing services market is segmented globally and by geographic regions. The service areas provided by preclinical CROs are extensively...
Medical Imaging Information Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update Summary Medical Devices sector report, “Medical Imaging Information Systems Pipeline Report including Stages of Development, Segments,...
400 pages •
By The Business Research Company
• Mar 2022
Major players in the biosimilar therapeutic peptides market are Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Amgen Inc., AstraZeneca PLC., GlaxoSmithKline (GSK), Novartis AG and Novo Nordisk A/S. The global biosimilar therapeutic peptides market is expected to grow from $0.93 billion in 2021 to $1.21...
The global CRO services market is estimated to grow at a CAGR of 11.0% during the forecast period. Growth in the CRO services market can mainly be attributed to factors such as the increasing investment in pharmaceutical R&D, rising number of clinical trials, high cost of in-house drug development (encouraging pharma-biotech companies to opt...
Restless Legs Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Restless Legs Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022...
Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Beta Nerve Growth Factor (Beta NGF or NGF) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules...
Drug Development
World
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.